Fortune 500 company

A Fortune 500 corporation, Eli Lilly had revenues of $14.6 billion in 2005, making it the 148th largest company in the United States. The company is publicly traded on the New York Stock Exchange and is a member of the S&P 500 stock index. Eli Lilly is one of the Nifty Fifty stocks that propelled the late 20th century bull market.

Pharmaceutical brands

Eli Lilly is a leading global manufacturer and distributor of pharmaceutical therapies for cancer, cardiovascular disease, central nervous system and endocrine system disorders, diabetes, infectious diseases, and other diagnoses.

Prozac

Among the company's major pharmaceutical breakthroughs are cephalosporin, erythromycin, insulin, and, with Prozac (fluoxetine), the world's first and most prominent selective serotonin reuptake inhibitor for the treatment of clinical depression. Prozac has been a breakthrough therapy, and the first such therapy in its class to treat clinical depression by stimulating the release of serotonin within the human brain. It is the best-selling anti-depressant in history and gave rise to a number of comparably-functioning therapies for the treatment of clinical depression and other central nervous system disorders.

Other therapies

In addition to Prozac, some of Lilly's famous product trademarks include Cymbalta (for pain and major depressive disorders), Darvocet (for pain), Evista (for the prevention and treatment of osteoporosis), Gemzar (a chemotherapy agent used in cancer treatment), Humalog (for diabetes), Humatrope (human growth hormone) and Zyprexa (used in the treatment of schizophrenia and bipolar disorder).